<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <originChamber>House</originChamber>
    <recordedVotes />
    <congress>114</congress>
    <title>To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.</title>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
      <actionDate>2015-05-15</actionDate>
    </latestAction>
    <notes />
    <updateDate>2018-11-21T21:23:14Z</updateDate>
    <amendments />
    <committees>
      <billCommittees>
        <item>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <type>Standing</type>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2015-05-15T19:43:07Z</date>
                </item>
              </activities>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2015-05-14T14:03:40Z</date>
            </item>
          </activities>
        </item>
      </billCommittees>
    </committees>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 161, Number 74 (Thursday, May 14, 2015)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. PITTS:H.R. 2338.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 1[Page H3213]</pre>]]></constitutionalAuthorityStatementText>
    <relatedBills>
      <item>
        <type>HR</type>
        <number>6</number>
        <congress>114</congress>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <latestAction>
          <actionDate>2015-07-13</actionDate>
          <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <latestTitle>21st Century Cures Act</latestTitle>
      </item>
    </relatedBills>
    <summaries>
      <billSummaries>
        <item>
          <updateDate>2015-05-14T04:00:00Z</updateDate>
          <actionDate>2015-05-14</actionDate>
          <text><![CDATA[<p>This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to establish processes under which: (1) an entity seeking to develop patient experience data may submit initial research concepts for feedback; (2) the FDA may request or receive from such an entity draft guidance documents, data, and summaries and analyses of data; and (3) patient experience data may be considered in the risk-benefit assessment of a new drug. </p> <p>&ldquo;Patient experience data&rdquo; is data collected by patients or others that is intended to facilitate the FDA's risk-benefit assessments, including information about the impact of a disease or a therapy on patients' lives.</p> The FDA must convene workshops and publish guidance on the patient experience data processes described above.]]></text>
          <name>Introduced in House</name>
          <versionCode>00</versionCode>
          <lastSummaryUpdateDate>2015-09-03T15:36:11Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in House</actionDesc>
        </item>
      </billSummaries>
    </summaries>
    <createDate>2015-05-15T12:51:45Z</createDate>
    <billNumber>2338</billNumber>
    <billType>HR</billType>
    <cosponsors />
    <version>1.0.0</version>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2015-05-15</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <actionDate>2015-05-14</actionDate>
        <links />
      </item>
      <item>
        <committee />
        <text>Introduced in House</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <actionDate>2015-05-14</actionDate>
        <links />
      </item>
      <item>
        <committee />
        <text>Introduced in House</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <actionDate>2015-05-14</actionDate>
        <links />
      </item>
      <actionTypeCounts>
        <placeholderTextForH>1</placeholderTextForH>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
    </actions>
    <laws />
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.</title>
        <chamberName />
        <chamberCode />
        <parentTitleType />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.</title>
        <chamberName />
        <chamberCode />
        <parentTitleType />
      </item>
    </titles>
    <cboCostEstimates />
    <sponsors>
      <item>
        <byRequestType />
        <lastName>PITTS</lastName>
        <middleName>R.</middleName>
        <state>PA</state>
        <identifiers>
          <lisID>1514</lisID>
          <gpoId>8134</gpoId>
          <bioguideId>P000373</bioguideId>
        </identifiers>
        <bioguideId>P000373</bioguideId>
        <fullName>Rep. Pitts, Joseph R. [R-PA-16]</fullName>
        <firstName>JOSEPH</firstName>
        <district>16</district>
        <party>R</party>
      </item>
    </sponsors>
    <committeeReports />
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Research administration and funding</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <introducedDate>2015-05-14</introducedDate>
    <calendarNumbers />
    <policyArea>
      <name>Health</name>
    </policyArea>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

